BioClinica is looking to target its new offering to the CROs and sponsors who have yet to adopt a cloud-based solution for the management and delivery of clinical trials.
Almac will transfer its custom peptide manufacturing business to a site at the Edinburgh Technopole business park in Scotland’s capital in a £3.5m move designed to expand capacity.
In the future pharma will be reliant on technology, says physician-scientist Daniel Kraft, who warns that companies which fail to innovate risk being left behind.
Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.
US contractor SAFC has joined the growing list of drugmakers and CMOs to invest in ADCs by announcing plans to add commercial-scale production capacity.
Over the last decade single-use technologies have moved into manufacturing scales and are increasingly being deployed worldwide, according to Thermo Fisher Scientific.
ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.
Tasi Group has bought Bonfiglioli Engineering, creating what it claims is the largest leak testing and quality inspection technology firm in the world.
New developments in the delivery space with Depomed signing up another Big Pharma licensee, Silence teaming up to test its tech for MiReven and Micropoint securing development funds for its microneedle system.
Bosch Packaging Technology says India is becoming one of its key markets, citing the growing pharma sector as a key driver for the development of its new Goa facility
The implementation of single use technology in the biopharmaceutical fill and finish process has seen a massive uptick recently because of better industry understanding, according to Pall’s Bruce Rawlings.
EMD Millipore premiered a new single-use bioreactor at Interphex 2012, claiming the new design addresses industry demand for ease of use and flexibility.
Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money
How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.
Demand for high-end capsule filling technologies, particularly those used for early clinical development projects, has increased in 2010 according to Capsugel.
The US FDA and NIH are funding research into bioinformatics-modelling of nanoparticles as part of a collaborative initiative to advance regulatory science.
West Pharmaceutical Services and Japan’s Daikyo Seiko team on container technology they claim will help drugmakers ensure consistency during scale-up operations
DSM Biologics says combining its XD platform with newly-acquired Rhobust chromatography platform will create high yield, low cost bio-manufacturing option.
NanoGuardian has licensed its NanoEncryption technology to Capsugel, a division of Pfizer, for use as an anti-counterfeiting system on the company’s capsule-based medications.
Arch Pharmalabs is continuing its push to serve innovative pharma by adding simulated moving bed (SMB) technology, becoming the first in India to offer the offer the system for plant scale API manufacture.
Executives in pharmaceutical companies tasked with implementing an anti-counterfeiting strategy already have a difficult job assessing a frankly bewildering array of technological solutions.
Biotage has announced plans to shift its business focus to the
environmental analysis sector - an industry on the rise as soaring
world population demands more efficient and safe laboratory
technologies to deal with waste, hazardous...
Finnish company DelSitech has signed a license agreement with Bayer
Innovation, a subsidiary of the Germany's Bayer group, in a deal
that could lead to the creation of a new generation of wound care
products.
Roche has invested $20m in a new technology that has the potential
to dramatically enhance the delivery of subcutaneous drugs by
acting like a 'molecular machete'.
Global packaging giant MeadWestvaco has acquired Saint-Gobain
Calmar, a manufacturer of plastic dispensing and spraying systems,
looking to establish a solid footing in primary packaging.
Bosch Packaging Technology will be launching new packaging and
processing technologies for pharmaceutical applications at Achema,
with products that cover pharmaceutical production, validation, and
packaging.
Invitrogen has announced two additional acquisitions in the area of
nanotechnologcal tools for target and drug discovery, just as it
completes the earlier-announced purchase of Biosource
International.
The acquisition of Flexible Packaging (FlexPac) of the US by the
Blackard Group will spur the development of the company's
technology into new industrial sectors, including pharmaceuticals.
The contract manufacturing market for biologicals will more than
double over the next six years, but production costs are higher
than necessary because 'downstream' processing is being ignored.
Capsule technology company BioProgress has reported its first set
of interim results since becoming an AIM-listed company, as well as
a distribution deal with Hoefliger.
Clariant has announced plans to establish a Technology Centre in
Germany that will support the pharmaceutical industry in the
commercialisation of new drugs.
German packaging company Bosch Packaging Technology will reveal a
host of products at the upcoming exhibition on chemical engineering
and biotechnology to be held in Frankfurt, Germany in May this
year. Brand new on the stand, filling...
